Study | All-Cause Mortality | Bleeding | Disabling and nondiasbling stroke | Combined end-pointa | Stroke at early follow-up (30-day) | |||||
---|---|---|---|---|---|---|---|---|---|---|
NOAC | VKA | NOAC | VKA | NOAC | VKA | NOAC | VKA | NOAC | VKA | |
Seeger et al., 2017 [26] | 19 (81) | 6 (50) | 5 (81) | 7 (50) | 1 (81) | 1 (50) | 22 (81) | 9 (50) | 3 (141) | 7 (131) |
Geis et al., 2018 [27] | 12 (154) | 11 (172) | 3 (154) | 3 (172) | 5 (154) | 2 (172) | 17 (154) | 14 (172) | N/A | N/A |
Jochheim et al., 2019 [28] | 47 (326) | 70 (636) | 69 (326) | 146 (636) | 10 (326) | 13 (636) | 63 (326) | 87 (636) | 5 (326) | 6 (636) |
Butt et al., 2019 [29] | 15 (99) | 54 (357) | 11 (94) | 28 (343) | 8 (93) | 14 (346) | N/A | N/A | 0 (213) | 3 (516) |
Kalogeras et al., 2019 [31] | 13 (115) | 16 (102) | 6 (115) | 9 (102) | N/A | N/A | N/A | N/A | N/A | N/A |
Kosmidou et al., 2019 [30] | 33 (155) | 207 (778) | 8 (155) | 43 (778) | 12 (155) | 41 (778) | N/A | N/A | N/A | N/A |
GALILEO, 2020 [32] | 64 (826) | 38 (818) | 46 (826) | 31 (818) | 30 (826) | 25 (818) | 83 (826) | 68 (818) | N/A | N/A |